Last edition
News about Biotechnology
Rondo Therapeutics Begins First-in-Human Trial of Novel CD28 - Nectin-4 Bispecific for Solid Tumours
Rondo Therapeutics, a clinical-stage biopharmaceutical company developing next-generation T-cell engaging bispecific antibodies for solid tumours, has begun dosing patients in its phase 1/1b clinical trial of RNDO-564.
Biotechnology | 07/12/2025 | By Darshana | 420
Cytiva and Veeda Lifesciences Launch New HCP Services Centre
The collaboration between Cytiva and Veeda Lifesciences brings a dedicated Host Cell Protein (HCP) services centre offering comprehensive HCP coverage, characterization, and quantification assays, enabling global biopharma companies to enhance the safety, efficacy, and quality of their biologics development
Biotechnology | 28/11/2025 | By Dineshwori | 301
Teva secures EC approval for two denosumab biosimilars, Ponlimsi and Degevma
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd., has received marketing authorizations from the European Commission for its two denosumab biosimilars—Ponlimsi, referencing Prolia, and Degevma, referencing Xgeva.
Biotechnology | 27/11/2025 | By Darshana | 282
Biogen Inc. has entered into a research collaboration with Dayra Therapeutics to discover and develop oral macrocyclic peptides targeting high-priority immunological conditions.
Biotechnology | 26/11/2025 | By Darshana | 215
Harbour BioMed Advances Global Biotherapeutics Collaboration With AstraZeneca
The alliance focuses on discovering and developing next-generation biotherapeutics, including antibody-drug conjugates and T-cell engagers, by combining the scientific strengths of both companies.
Biotechnology | 25/11/2025 | By Darshana | 249
Freudenberg Expands Bioprocessing Capabilities at CPHI and PMEC India
The global manufacturer has introduced its CleanAssure system, a cleanroom-based sanitary washing and drying workstation that uses ultra-purified water and filtered air to enhance safety for single-use tubings and assemblies.
Biotechnology | 25/11/2025 | By Darshana | 216
India Unveils its First Indigenous CRISPR-based Gene Therapy 'BIRSA 101' for Sickle Cell Disease
India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free nation, with Union Minister of State for Science & Technology Dr. Jitendra Singh launching the country's first indigenous CRISPR-based gene therapy for the condition.
Biotechnology | 20/11/2025 | By Dineshwori | 937
EirGenix Signs Second Global Licensing Deal With Sandoz for Pertuzumab Biosimilar
EirGenix Inc., a Taiwan-based biopharmaceutical and CDMO company, has signed a second global exclusive licensing agreement with Sandoz AG for the commercialization of its pertuzumab biosimilar EG1206A, developed as an alternative to Roche’s Perjeta.
Biotechnology | 14/11/2025 | By Darshana | 325
Dyadic International, Inc. (operating as Dyadic Applied BioSolutions), a US-based biotechnology innovator, has appointed international business development consultancy Intralink to expand its commercial presence in Japan and South Korea — two of Asia’s fastest-growing and most advanced biopharmaceutical markets.
Biotechnology | 10/11/2025 | By Darshana | 318
Bharat Biotech Launches Nucelion, a New CRDMO Focused on Cell and Gene Therapies
The new entity, based in Genome Valley, Hyderabad, is designed to partner with global life-science innovators to deliver end-to-end solutions for complex biologic medicines.
Biotechnology | 03/11/2025 | By Darshana | 543
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy